Inflation relief, AI cutting bank jobs even as profits soar, OpenAI cutting the government in on its equity — and is SpaceX the next $2 trillion picks-and-shovels play?
We're joined by Miles Harrison, CEO of Conexeu Sciences (Nasdaq: CNXU), to discuss the intersection of AI and bioscience + how GLP-1s are carving out a new market for them.
Robert and Austin talk about SpaceX breaking Wall Street's rules to be included in the Nasdaq-100, inflation printing 4.2%, and Apple's WWDC Siri AI announcement.
Milliman’s Adam Schenck explains why healthcare inflation may be one of the biggest threats to retirement—and how a new generation of ETFs aims to address it.
From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey and get exclusive early access to the final report.